NASDAQ:BCTX Briacell Therap Q2 2026 Earnings Report $4.32 +0.04 (+0.93%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$4.35 +0.03 (+0.67%) As of 09/25/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Briacell Therap EPS ResultsActual EPS-$2.58Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABriacell Therap Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABriacell Therap Announcement DetailsQuarterQ2 2026Date3/10/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Briacell Therap Earnings HeadlinesBriacell Therap (NASDAQ:BCTX) Short Interest UpdateSeptember 18, 2026 | americanbankingnews.comData Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer StudySeptember 14, 2026 | markets.businessinsider.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery. | Behind the Markets (Ad)Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer StudySeptember 14, 2026 | globenewswire.comBriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer CenterSeptember 8, 2026 | globenewswire.comBriaCell shares turn volatile after melanoma vaccine development milestoneAugust 24, 2026 | msn.comSee More Briacell Therap Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Briacell Therap? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Briacell Therap and other key companies, straight to your email. Email Address About Briacell TherapBriacell Therap (NASDAQ:BCTX)eutics Corp. (NASDAQ:BCTX) is a biotechnology company focused on developing targeted immunotherapies for cancer. The company’s research centers on cell-based therapies designed to stimulate a patient’s immune system to recognize and attack tumor cells, with an emphasis on difficult-to-treat solid tumors. BriaCell’s lead technology, Bria-IMT, is an immunotherapy derived from a proprietary breast cancer cell line. The company has studied Bria-IMT in patients with advanced or metastatic breast cancer, including in combination with immune checkpoint inhibitors. BriaCell has also been developing Bria-OTS, an off-the-shelf cell-based immunotherapy intended to provide a more broadly available treatment option without requiring an individualized product for each patient. Founded in 2006, BriaCell is a Canadian biotechnology company with operations in North America. Its programs have primarily focused on advanced breast cancer, while the company has also explored broader applications of its immunotherapy platform in other solid tumors. William Williams has served as the company’s president and chief executive officer.View Briacell Therap ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura Deal Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
